Cardiologists Weigh Where the First Oral PCSK9 Pill Fits Now That the FDA Has Approved It

The FDA approved the first oral PCSK9 inhibitor in July. Cardiologists explain where it fits alongside statins and what remains unproven.

Have A Referral?